Irish Wolfhound Type Cardiomyopathy, 2021

William D. Tyrrell, Jr., DVM, DACVIM (Cardiology)

The most common form of heart disease in the Irish Wolfhound (IW) is Irish Wolfhound type Cardiomyopathy (IWCM). This disease state was formerly referred to as dilated cardiomyopathy (DCM). The IW does not often have typical DCM and cardiomyopathy better describes IW heart disease.

Greater than 99% of IWs with IWCM will have concurrent atrial fibrillation, an arrhythmia affecting the top chambers of the heart called the atria. The IW with heart disease typically has a longer survival time than breeds such as the Boxer, Doberman Pinscher, and Great Dane – breeds with classic DCM.

Clinical signs of heart disease in the IW typically relate to both the onset of atrial fibrillation (irregular heart rhythm also known as afib) as well as progressive left-sided congestive heart failure (fluid in the lungs or pulmonary edema).

Atrial fibrillation, an arrhythmia of the heart, is characterized as a rapid, irregularly irregular heart rhythm and can be analogous to listening to sneakers in a spinning clothes dryer or jungle drums. The IW affected with atrial fibrillation is typically exercise intolerant, weak, or just “off.” The owner may note a decrease in appetite or lack of desire to go on walks. However, many hounds with afib - often those with slower heart rates - have no symptoms, which makes periodic screening for this arrhythmia even more important

Clinical signs relating to left-sided congestive heart failure include labored or rapid breathing, coughing, and exercise intolerance. The owner may note their IW will not lie down on their side (lateral recumbency) and will sit or lie with the head upright as this position makes it easier to breathe. 

Irish Wolfhound Cardiomyopathy

The North American experience with IW cardiomyopathy is a little different than what is usually seen in other large breed dogs commonly affected with heart disease.

These findings were recently reported in the Journal of Veterinary Internal Medicine (Tyrrell et al, February 29, 2020) in a study supported by the Irish Wolfhound Foundation. The disease usually begins with the onset of atrial fibrillation. Predictive values from this data showed that in the absence of atrial fibrillation there is only a .2% chance the hound has echocardiogram abnormalities. The electrocardiogram, a.k.a., EKG or ECG, (much less expensive and more easily available) can be used as a screening test for IW heart disease.

Initially after afib is found, the heart size and function may be normal, or the left atrium may be minimally enlarged. As time and the disease progress, the left atrium becomes increasingly enlarged or dilated. The left ventricle will enlarge as well, however, not to the extent that we see in breeds with typical DCM. Additionally, the left ventricle’s systolic function or pumping ability is usually not severely depressed as in canine breeds with DCM. Right-sided congestive heart failure (fluid in the chest or belly) can uncommonly occur at an extremely late stage in the progress of IWCM. 

Treatment depends on the stage of the disease. Early detection and early medical intervention have been shown to prolong the lives of IWs for years. A recent article in the Journal of Veterinary Internal Medicine (Vollmar et al, 2016) showed that IWs with preclinical heart disease that are treated with pimobendan/Vetmedin® had a significantly prolonged time to onset of congestive heart failure.

Your IW should be examined at least yearly by your veterinarian, and as they age to over four years, twice yearly examinations are recommended. An electrocardiogram (EKG/ECG) should be run on an annual basis by your veterinarian and then ideally twice yearly if your IW is over the age of four as the incidence of heart disease in the IW increases with age..

If your veterinarian hears an arrhythmia or heart murmur, consultation with a veterinary cardiologist, if possible, is further recommended. Medication can both improve overall quality and duration of life. 

Medical therapy is aimed at the following:

Preclinical Disease Treatment (your IW has atrial fibrillation without evidence of congestive heart failure):

• Arrhythmia control: Medications such as digoxin, sotalol or diltiazem are used to help slow the overall heart rate of atrial fibrillation. A target resting heart rate in the home environment of 80-100 beats per minute is desired and medication dosage may need adjustment. Monitoring of your IW’s heart rate and rhythm at home is a great way to help your veterinary cardiologist treat your IW’s heart disease. Obtaining an inexpensive stethoscope can help you monitor your IW’s heart rate or you can use an AliveCor® device on your smartphone which will allow you to monitor their electrocardiogram and heart rate. Electrical conversion of atrial fibrillation is not commonly attempted in veterinary medicine and has not been shown to be successful. Your IW with atrial fibrillation is not at risk for a stroke like people are with this arrhythmia.
• Medications such as Pimobendan (Vetmedin®) and an ACE inhibitor, such as Enalapril or Benazepril, help to both improve the strength of the heart muscle and dilate the arteries in the body, thus improving the overall efficiency of the heart as the blood pumps.
• Depending on the stage of your IW’s heart disease, a weak diuretic that helps block a hormone called aldosterone may be added into your dog’s treatment regimen. This drug works with an ACE inhibitor (enalapril/benazepril) to more completely block some bad hormones that are produced during heart disease.

Congestive Heart Failure (CHF) Treatment (your IW has symptoms of cough, shortness of breath, etc. from fluid in their lungs):

• When or if your IW goes into CHF, all the above medications are continued including Pimobendan (Vetmedin®). The dosage of this medication may be increased by a cardiologist to help control heart failure symptoms. Additionally, diuretic therapy (Lasix®/Salix®/Furosemide) will be started to help alleviate the fluid or congestion in the lungs secondary to left-sided congestive heart failure.

Ultimately, the early detection of IWCM is what is desired as treatment of the pre-clinical patient can make a large difference in your dog’s quantity and quality of life. Working with your primary care veterinarian to have annual or biannual EKGs is highly recommended to help diagnose this very treatable and manageable heart disease in your IW.